v3.26.1
Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue:        
Total revenue $ 961,138 $ 966,630 $ 2,072,094 $ 1,360,202
Costs and expenses:        
Costs of research and development revenue 123,322 148,457 463,479 274,937
Costs of grant revenue 860,843 465,134 1,312,526 636,312
Research and development 332,621 629,379 808,690 1,124,358
General and administrative 1,689,863 1,436,630 3,445,194 3,032,968
Foreign currency exchange (gain) loss 8,693 16,098 (898) 23,170
Total costs and expenses 3,015,342 2,695,698 6,028,991 5,091,745
Loss from operations (2,054,204) (1,729,068) (3,956,897) (3,731,543)
Other income (expense):        
Interest income 39,705 49,127 96,896 137,585
Total other expense, net (69,680) (64,706) (121,670) (89,810)
Net loss $ (2,123,884) $ (1,793,774) $ (4,078,567) $ (3,821,353)
Basic net loss per common share $ (0.06) $ (0.06) $ (0.11) $ (0.13)
Diluted net loss per common share $ (0.06) $ (0.06) $ (0.11) $ (0.13)
Basic weighted-average common shares outstanding 36,438,703 30,102,324 36,418,462 30,071,285
Diluted weighted-average common shares outstanding 36,438,703 30,102,324 36,418,462 30,071,285
Nonrelated Party [Member]        
Other income (expense):        
Interest expense $ (64,479) $ (89,456) $ (128,821) $ (178,699)
Related Party [Member]        
Other income (expense):        
Interest expense (44,906) (24,377) (89,745) (48,696)
Research And Development Expenses [Member]        
Revenue:        
Total revenue 123,886 213,449 527,476 396,549
Grant [Member]        
Revenue:        
Total revenue 837,252 503,181 1,324,618 713,653
License [Member]        
Revenue:        
Total revenue $ 250,000 $ 220,000 $ 250,000